NAV — Navco Pharmaceuticals Cashflow Statement
0.000.00%
Last trade - 00:00- CA$0.57m
- CA$0.64m
Annual cashflow statement for Navco Pharmaceuticals, fiscal year end - September 30th, CAD millions except per share, conversion factor applied.
2022 June 30th | 2023 September 30th | 2024 September 30th | 2025 September 30th | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final |
| Net Income/Starting Line | -0.094 | -2.15 | -1.72 | -0.079 |
| Depreciation | ||||
| Amortisation | ||||
| Non-Cash Items | — | 0.947 | 0.851 | 0.01 |
| Unusual Items | ||||
| Other Non-Cash Items | ||||
| Changes in Working Capital | 0.083 | -0.62 | 0.544 | 0.047 |
| Change in Accounts Receivable | ||||
| Change in Inventories | ||||
| Change in Prepaid Expenses | ||||
| Change in Accounts Payable | ||||
| Change in Accrued Expenses | ||||
| Change in Payable / Accrued Expenses | ||||
| Cash from Operating Activities | -0.01 | -1.78 | -0.253 | -0.021 |
| Financing Cash Flow Items | — | -0.029 | 0 | — |
| Other Financing Cash Flow | ||||
| Net Issuance / Retirement of Stock | ||||
| Net Issuance / Retirement of Debt | ||||
| Cash from Financing Activities | 0 | 2.01 | 0.026 | 0.017 |
| Beginning Cash Balance | ||||
| Ending Cash Balance | ||||
| Net Change in Cash | -0.01 | 0.233 | -0.227 | -0.004 |